A new human synovial sarcoma cell line, HS-SY-3, with a truncated form of hybrid SYT/SSX1 gene

Hiroshi Sonobe, Tamotsu Takeuchi, Sheng Ben Liag, Takahiro Taguchi, Kazunari Yuri, Kiichi Shimizu, Jun Iwata, Mutsuo Furihata, Yuji Ohtsuki, Joseph R. Testa

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

Recent cytogenetical and molecular studies have indicated that synovial sarcoma harbors a t(X;18)(p11.2;q11.2) translocation, resulting in the formation of a hybrid SYT/SSX (SSX1 or SSX2) gene. We newly established a human cell line, HS-SY-3, from a synovial sarcoma. HS-SY-3 cells were shown to harbor the pathognomonic t(X;18)(p11.2;q11.2) translocation by chromosome analysis but not to exhibit the classical hybrid SYT/SSX transcripts induced by this translocation, using RTPCR. To determine the reason for this discrepancy, we analyzed cDNA from HS-SY-3 cells, as well as the original sarcoma tissue by the rapid amplification of cDNA 3' end assay, and found that the chimaeric cDNA was 240 bp shorter than the previously established SYT/SSX1 cDNA due to truncation of the 3' side of SSX1. The HS-SY-3 cells should be useful for future functional studies of the SYT/SSX chimeric gene.

Original languageEnglish
Pages (from-to)459-464
Number of pages6
JournalInternational Journal of Cancer
Volume82
Issue number3
DOIs
StatePublished - 1999

Keywords

  • Aged
  • Aged, 80 and over
  • Female
  • Gene Amplification
  • Humans
  • Hybridization, Genetic
  • In Situ Hybridization, Fluorescence
  • Karyotyping
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sarcoma, Synovial/genetics
  • Translocation, Genetic
  • Tumor Cells, Cultured

Fingerprint

Dive into the research topics of 'A new human synovial sarcoma cell line, HS-SY-3, with a truncated form of hybrid SYT/SSX1 gene'. Together they form a unique fingerprint.

Cite this